Highlights:

  • Corero records Q3 2025 order intake of USD 7.4 million, up from USD 6.0 million in Q3 2024.
  • Secures USD 6.8 million renewal and expansion with leading US cloud provider in October 2025.
  • Announces platform enhancements including Layer 7 TLS Protection and Zero Trust Admission Control.

Corero Network Security plc (LSE:CNS), a provider of distributed denial of service (DDoS) protection solutions, reported order intake of USD 7.4 million for Q3 2025, compared with USD 6.0 million in the same period in 2024. New contracts were secured across the US, UK, Europe, Brazil, and Singapore.

Two additional CORE2 solution customer wins were added in Q3 2025, following the first two CORE contracts secured in Q2 2025.

Customer Renewal and Expansion

In October 2025, Corero secured a renewal and expansion order with a leading US cloud computing provider. The total contract value is USD 6.8 million, comprising USD 3.1 million for the renewal of existing contracts and USD 3.7 million for the expansion across the customer’s current and planned data centers. Of this, USD 0.8 million was included in Q3 2025 order intake. The contract will be delivered and recognized on a subscription basis over three years.

Product Platform Enhancements

Corero also introduced several platform enhancements in H2 2025 to support customer requirements:

  • Layer 7 TLS Protection: Blocks high-volume application-layer attacks in real time at the network edge without additional latency, false positives, or hardware.
  • Zero Trust Admission Control: Detects and blocks anomalies at login portals using behavioral analytics, reducing credential abuse and bot-driven attacks.
  • Extended WAF and Application Security for Service Providers: Protects web applications and APIs using adaptive analytics, threat modeling, and anti-bot capabilities.
  • Bare Metal and COTS Deployment Options: Expands software-led, hardware-agnostic deployment for customers preferring specific hardware environments.

FY 2025 Guidance

Management reaffirmed revenue guidance for FY 2025 between USD 24.0 million and USD 25.5 million (FY 2024: USD 24.6 million) and EBITDA guidance between a USD 1.5 million loss and USD 0 million (FY 2024: USD 2.5 million profit).

Share performance of CNS

CNS’s shares traded at GBX 9.22 per share on 05 November 2025, up by 5.31% from its previous close of GBX 8.85.